None listed
Conditions
Interventions
Group 1 Type of group
A 10 mg ampoule of Propinox Hydrochloride will be administered.
Group name:Group 2 Type of group
IV Placebo will be administered
Sponsors
VICTOR H. MENDOZA PEÑA,
Eligibility
Inclusion criteria
Inclusion criteria: • Women pregnant for the first time with term pregnancies, without complications of cervical dystocia; in cephalic presentation, in labor: ACTIVE PHASE with 4 cm of cervical dilatation, no RPM.
Exclusion criteria
Exclusion criteria: • Women pregnant for the first time whose pregnancy is diagnosed premature or Post-mature. • Antecedents of gynecological and obstetric pathologies. • Drug allergy to Propinox hydrochloride because it contains pargeverine. • Previous Diagnosis of Cervical Dystocia. • Systemic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:Tocolytic effect in the active phase of labor Measure:Effect of propinox clorhidrate Timepoints:During labor | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name:Shortening of active phase Measure:Duration of the active phase Timepoints:Until delivery ; Outcome name:Adverse efects registry Measure:Side effects of Propinox Hydrochloride Timepoints:During labor | — |
Outcome results
None listed